Current Neuropharmacology
Title: PREFACE
Volume: 10 Issue: 1
Author(s): Thomas E. Salt
Affiliation:
Export Options
About this article
Cite this article as:
E. Salt Thomas, PREFACE, Current Neuropharmacology 2012; 10 (1) . https://dx.doi.org/10.2174/157015912799362797
DOI https://dx.doi.org/10.2174/157015912799362797 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Proton Magnetic Resonance Spectroscopy as a Monitoring Tool for Electroconvulsive Therapy Effects on the Brain
Current Psychiatry Reviews Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism
Current Drug Metabolism Neuronal and Vascular Oxidative Stress in Alzheimers Disease
Current Neuropharmacology Herb-Drug Interactions in Neurological Disorders: A Critical Appraisal
Current Drug Metabolism Gabapentin-Mediated Effects on Voltage- and Ligand-Gated Currents
Current Neuropharmacology The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Strategies to Treat Substance Abuse and Addiction (Guest Editor: Christopher R. McCurdy)]
Current Topics in Medicinal Chemistry Ameliorative Effect of Trans-Sinapic Acid and its Protective Role in Cerebral Hypoxia in Aluminium Chloride Induced Dementia of Alzheimer's Type
CNS & Neurological Disorders - Drug Targets Targeting the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in the Central Nervous System: Potential Therapy for Inflammatory Demyelinating Disease?
Current Neurovascular Research Failure Mode and Effects Analysis to Reduce Risks of Errors in the Good Manufacturing Practice Production of Engineered Cartilage for Autologous Chondrocyte Implantation
Current Pharmaceutical Analysis Neuroprotective Role of Agmatine in Neurological Diseases
Current Neuropharmacology Allosteric Modulators of Class B G-Protein-Coupled Receptors
Current Neuropharmacology Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods
Current Protein & Peptide Science Recent Advances in Regulatory T Cell Therapy of Autoimmunity, Graft Rejection and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery COMMENTARY: Magnetic Resonance Techniques Applied to Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Defining Primary and Secondary Progenitor Disorders in the Brain: Proteomic Approaches for Analysis of Neural Progenitor Cells
Current Pharmaceutical Biotechnology microRNAs-based Predictor Factor in Patients with Migraine-ischemic Stroke
MicroRNA ABC Transporters in the CNS – An Inventory
Current Pharmaceutical Biotechnology Human Amylin: From Pathology to Physiology and Pharmacology
Current Protein & Peptide Science The Role of Cnidaria in Drug Discovery. A Review on CNS Implications and New Perspectives
Recent Patents on CNS Drug Discovery (Discontinued)